If the project data is submitted to other national administrative departments in stages, is it necessary to apply information back up and filing? | BradyKnows

Subscribe

Providing human genetic resources information to foreign entities other than the cooperative parties requires information backup and filing.

Suggested Reading

What factors may affect biocompatibility risk when using biological test data from similar devices for…
What are the key focus areas in the evaluation of acute, subacute, subchronic, and chronic toxicity, and can…
When combining subchronic and implantation tests in one project, what factors need to be considered, and how can…
Do all medical devices require chemical characterization?
Can products made from materials conforming to YY 0341.1 Appendix B be exempted from biological evaluation?
How is the endotoxin limit for wound dressing products determined?
How should the evaluation of new items in the endpoint table be considered after the implementation of the new…
For subchronic systemic toxicity studied via implantation, what is the basis for determining the implantation…
Under what conditions can the extraction liquid of dressings be accepted after pH adjustment, centrifugation,…
GB/T 16886.11-2021 adds tests for subchronic systemic toxicity evaluation with dual-route exposure. Which…
GB/T 16886.1-2022 includes implantation in the biological evaluation of dressings. How should implantation tests…
Why is the extraction period typically 24 hours in China for cytotoxicity testing?

Previous: If there are different receivers, does the information need to be backed up and filed separately?

Next: An international cooperative clinical study is divided into two applications: registration and exploratory. Does it need to apply for backup and filing separately for the outbound data information?